Evidence map›Paper›PMID 31413748›Full record

ArticleJournal of Cancer2019

High Expression Levels of

Xinrui Yang, Yifan Pang, Jilei Zhang, Jinlong Shi, Xinpei Zhang, Gaoqi Zhang, Siyuan Yang, Jing Wang, Kai Hu, Jijun Wang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Placental-Cadherin, a biomarker for local immune status and poor prognosis among patients with tongue squamous cell carcinoma.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Pooled it
  2. LncRNA AC098613.1 promotes acute myeloid leukemia cell differentiation through CDC5L/ADAP1/NRD1 axis.Apoptosis : an international journal on programmed cell death · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The mechanobiome: a goldmine for cancer therapeutics.American journal of physiology. Cell physiology · 2021
    Review
  13. International journal of nanomedicine · 2021
    Article
  14. Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Xinrui YangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Yifan PangDepartment of Medicine, William Beaumont Hospital, Royal Oak, MI 48073, USA.
Jilei ZhangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Jinlong ShiDepartment of Biomedical Engineering, Chinese PLA General Hospital, Beijing, 100853, China.
Xinpei ZhangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Gaoqi ZhangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Siyuan YangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Jing WangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Kai HuDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Jijun WangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Hongmei JingDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Xiaoyan KeDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Lin FuDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Peking University Third Hospital · CNPeking University · CNBeaumont Hospital, Royal Oak · USChinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACTN1ACTN3acute myeloid leukemiaprognosis

Identifiers

PMID31413748
PMCPMC6691690
OpenAlexW2963690340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.